Mkts

Mirum Pharmaceuticals, Inc.

NASDAQ: MIRM
$92.49+0.54 (+0.59%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
90.9693.00
52-week range
63.23130.00
Today
Open91.53
Previous close92.49
Volume—
Valuation
Market cap6.03B
P/E ratio—
EPS (TTM)-15.22
Income & risk
Dividend / yield—
Beta0.71
Avg volume684.8K
Discussion

MIRM News

Stories mentioning MIRM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue159,882148,932133,010127,785111,58599,41490,37777,875
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin96,33074,12861,91063,28657,70656,83050,54549,208
Total Operating Expenses949,347153,499130,407132,774126,768123,636103,061102,107
Operating Income (Loss)(789,465)(4,567)2,603(4,989)(15,183)(24,222)(12,684)(24,232)
Interest Income3,4013,4203,2513,0333,0233,2043,4693,486
Interest Expense
Other Expense0.00(218.00)395.0086.002,108231.00(1,087)312.00
Pretax Income(789,680)(4,963)2,643(5,459)(13,648)(24,366)(13,888)(24,003)
Tax Provision475.00767.00(262.00)402.001,029(576.00)347.00635.00
Net Income (Loss)(790,155)(5,730)2,905(5,861)(14,677)(23,790)(14,235)(24,638)
Earnings Per Share (Basic)(13.43)(0.11)0.06(0.12)(0.30)(0.50)(0.30)(0.52)
Earnings Per Share (Diluted)(13.43)(0.11)0.05(0.12)(0.30)(0.50)(0.30)(0.52)
Weighted Average Shares Outstanding (Basic)58,85150,19850,63949,72748,88947,52347,78347,235
Weighted Average Shares Outstanding (Diluted)58,85150,19856,99449,72748,88947,52347,78347,235

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MIRM

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a stock listed on the Nasdaq Stock Market under the ticker symbol MIRM. It last traded at $92.49 (Nov 18, 2026, 4:00 PM ET), up 0.6% on the day. That gives Mirum Pharmaceuticals a market capitalisation of $6.0B.

Over the past 52 weeks MIRM has traded between $63.23 and $130.00.

Revenue for the quarter ended Mar 31, 2026 was $159.9M; a net loss of $790.2M. Revenue was up 43.3% from $111.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$159.9M-$790.2M-494.2%
Dec 31, 2025$148.9M-$5.7M-3.8%
Sep 30, 2025$133.0M$2.9M2.2%
Jun 30, 2025$127.8M-$5.9M-4.6%

From Mirum Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…